Shuttle Pharmaceuticals (SHPH) Competitors $3.38 +0.07 (+2.11%) Closing price 03:59 PM EasternExtended Trading$3.35 -0.03 (-0.89%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. NKGN, JBIO, PLRZ, THAR, PPBT, PMCB, GTBP, VAXX, LIAN, and VYNEShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include NKGen Biotech (NKGN), Jade Biosciences (JBIO), Polyrizon (PLRZ), Tharimmune (THAR), Purple Biotech (PPBT), Nuvilex (PMCB), GT Biopharma (GTBP), Vaxxinity (VAXX), LianBio (LIAN), and VYNE Therapeutics (VYNE). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors NKGen Biotech Jade Biosciences Polyrizon Tharimmune Purple Biotech Nuvilex GT Biopharma Vaxxinity LianBio VYNE Therapeutics Shuttle Pharmaceuticals (NASDAQ:SHPH) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Is SHPH or NKGN more profitable? NKGen Biotech's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -772.76% -347.06% NKGen Biotech N/A N/A -479.36% Does the media favor SHPH or NKGN? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than NKGen Biotech. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for NKGen Biotech. Shuttle Pharmaceuticals' average media sentiment score of 0.33 beat NKGen Biotech's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Shuttle Pharmaceuticals Neutral NKGen Biotech Neutral Which has stronger earnings & valuation, SHPH or NKGN? Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.81NKGen BiotechN/AN/A-$82.94M-$2.45-0.05 Do institutionals & insiders believe in SHPH or NKGN? 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 10.4% of NKGen Biotech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, SHPH or NKGN? Shuttle Pharmaceuticals has a beta of -1.08, meaning that its share price is 208% less volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. SummaryShuttle Pharmaceuticals and NKGen Biotech tied by winning 5 of the 10 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45M$2.49B$5.73B$9.56BDividend YieldN/A1.66%4.53%4.08%P/E Ratio-0.8122.4830.4625.16Price / SalesN/A549.05392.5787.62Price / CashN/A173.7937.0358.50Price / Book0.415.268.956.21Net Income-$9.15M$31.83M$3.26B$265.38M7 Day Performance-3.43%0.82%1.06%-1.13%1 Month Performance-12.89%3.71%4.31%-0.71%1 Year Performance-93.17%9.37%28.39%18.86% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals1.0004 of 5 stars$3.38+2.1%N/A-93.4%$1.45MN/A-0.815NKGNNKGen BiotechN/A$0.14-17.6%N/A-83.8%$6.29MN/A-0.03N/AGap DownJBIOJade Biosciences2.2663 of 5 stars$7.39-0.1%$15.00+103.0%N/A$6.21MN/A-0.1220Positive NewsAnalyst RevisionGap UpPLRZPolyrizonN/A$1.01-1.9%N/AN/A$6.05MN/A0.00N/APositive NewsGap DownTHARTharimmune3.3049 of 5 stars$1.40+16.7%$17.00+1,114.3%+28.7%$5.91MN/A-0.182News CoverageEarnings ReportGap UpTrading HaltedPPBTPurple Biotech1.5075 of 5 stars$2.25+2.3%$33.00+1,366.7%N/A$5.83MN/A-5.3620Gap DownPMCBNuvilex1.3709 of 5 stars$0.84-4.1%N/A-48.3%$5.76MN/A1.144News CoveragePositive NewsHigh Trading VolumeGTBPGT Biopharma2.732 of 5 stars$1.75+0.5%$11.00+528.8%-51.1%$5.72MN/A-0.318Earnings ReportVAXXVaxxinityN/A$0.04+42,900.0%N/A+0.0%$5.45MN/A-0.1090Gap UpLIANLianBioN/A$0.05flatN/A-81.5%$5.43MN/A-0.06110VYNEVYNE Therapeutics2.1734 of 5 stars$0.35+1.9%$6.25+1,698.6%-82.1%$5.29M$500K-0.3530Earnings Report Related Companies and Tools Related Companies NKGN Alternatives JBIO Alternatives PLRZ Alternatives THAR Alternatives PPBT Alternatives PMCB Alternatives GTBP Alternatives VAXX Alternatives LIAN Alternatives VYNE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access